You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Olmesartan Medoxomil

Showing 1 - 25 of 155
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Arterial Hypertension Trial (Olmesartan medoxomil 40mg + chlorthalidone 12,5mg, Olmesartan medoxomil 40mg + chlorthalidone 25mg,

Not yet recruiting
  • Arterial Hypertension
  • Olmesartan medoxomil 40mg + chlorthalidone 12,5mg
  • +3 more
  • (no location specified)
Aug 3, 2022

Essential Arterial Hypertension Trial (Olmesartan Medoxomil 20mg + Chlorthalidone 12,5mg, Olmesartan medoxomil 20mg +

Not yet recruiting
  • Essential Arterial Hypertension
  • Olmesartan Medoxomil 20mg + Chlorthalidone 12,5mg
  • +2 more
  • (no location specified)
Aug 3, 2022

Angiotensin/Renin/Aldosterone Hypertension, Hypertension, Diabetes, Type 2 Trial in Seongnam (Olmesartan)

Recruiting
  • Angiotensin/Renin/Aldosterone Hypertension
  • +2 more
  • Seongnam, Gyeonggi, Korea, Republic of
    Seoul National University Bundang Hospital
Aug 16, 2022

OLOMAX for Blood Pressure and Low-density Lipoprotein

Recruiting
  • Hypertension
  • Dyslipidemias
  • Olmesartan Medoxomil/ Amlodipine Besylate/ Rosuvastatin Ca
  • Seoul, Korea, Republic of
    Seoul St.Mary's Hospital
Dec 13, 2022

Improving Systolic BP and LDL-C Compared to Conventional

Not yet recruiting
  • Hyperlipidemias
  • Hypertension
  • Rosuvastatin, Olmesartan Medoxomil
  • (no location specified)
Jun 6, 2022

Essential Hypertension Trial in Shenzhen (Sacubatril Allisartan medoxomil, Olmesartan Medoxomil)

Recruiting
  • Essential Hypertension
  • Sacubatril Allisartan medoxomil
  • Olmesartan Medoxomil
  • Shenzhen, Guangdong, China
    Shenzhen People' S Hospital
Aug 30, 2021

Hypertension Trial in Worldwide (OM 40, OM/HCTZ 40/12.5)

Completed
Has Results
  • Hypertension
  • OM 40
  • OM/HCTZ 40/12.5
  • Rijeka, Croatia
  • +64 more
Jul 8, 2021

Therapeutic Effectiveness and Safety of Olomax Tab

Enrolling by invitation
  • Hypertension
  • Dyslipidemia
  • Olmesartan Medoxomil
  • Hwaseong-si, Gyeonggi, Korea, Republic of
    Hallym University Dongtan Sacred Heart Hospital
Dec 21, 2021

Amlodipine And Olmesartan Medoxomil In Hypertensive Filipino

Terminated
Has Results
  • Hypertension
  • Amlodipine + Olmesartan medoxomil
  • San Fernando City, LA Union, Philippines
  • +56 more
Jul 26, 2021

Bioequivalence Trial in Mont-Royal (Olmesartan Medoxomil/Hydrochlorothiazide 40 Mg/25 Mg film-coated tablets for oral use,

Unknown status
  • Bioequivalence
  • Olmesartan Medoxomil/Hydrochlorothiazide 40 Mg/25 Mg film-coated tablets for oral use
  • Olmetec® Plus 40 Mg/25 Mg film-coated tablets for oral use
  • Mont-Royal, Quebec, Canada
    Altasciences Company Inc.
Dec 2, 2019

Hypertension Trial in Schwerin (Amlodipine, Olmesartan medoxomil, Amlodipine+valsartan)

Completed
Has Results
  • Hypertension
  • Schwerin, Germany
  • +1 more
Jul 27, 2020

Primary Hypertension Trial (Amlodipine, Olmesartan, Hydrochlorothiazide)

Not yet recruiting
  • Primary Hypertension
  • (no location specified)
Jun 15, 2023

Bioequivalence Trial in Mont-Royal (Olmesartan Medoxomil 40 mg, Olmetec®)

Completed
  • Bioequivalence
  • Mont-Royal, Quebec, Canada
    Altasciences Company Inc.
Jul 26, 2019

Hypertension, Hypertension,Essential Trial (fixed-dose of olmesartan 20mg/40 mg + indapamide 1,5 mg, Isolated drugs Olmesartan

Not yet recruiting
  • Hypertension
  • Hypertension,Essential
  • fixed-dose of olmesartan 20mg/40 mg + indapamide 1,5 mg
  • Isolated drugs Olmesartan (20 mg or 40 mg) and Indapamide (1,5 mg)
  • (no location specified)
Mar 17, 2022

Hypertension, Hyperlipidemias Trial in Seoul (Amlodipine/Olmesartan 10/40mg (Combination drug), Rosuvastatin 20mg, Olmesartan 40

Completed
  • Hypertension
  • Hyperlipidemias
  • Amlodipine/Olmesartan 10/40mg (Combination drug), Rosuvastatin 20mg
  • +2 more
  • Seoul, Korea, Republic of
    Seoul national university bundang hospital
Dec 20, 2021

Metabolic Syndrome, Hypertension Trial in Ghent, Nurnberg, Monza (olmesartan medoxomil, )

Completed
  • Metabolic Syndrome
  • Hypertension
  • olmesartan medoxomil
  • placebo
  • Ghent, Belgium
  • +2 more
Dec 20, 2018

Metabolic Syndrome, Hypertension Trial in Erlangen (Olmesartan medoxomil tablets low dose, Olmesartan medoxomil tablets high

Completed
  • Metabolic Syndrome
  • Hypertension
  • Olmesartan medoxomil tablets low dose
  • +2 more
  • Erlangen, Germany
    (unnamed)
Dec 20, 2018

Chronic Heart Failure, High Blood B-type (or Brain) Natriuretic Peptide (BNP) Level Trial in France, Germany, Netherlands

Terminated
  • Chronic Heart Failure
  • High Blood B-type (or Brain) Natriuretic Peptide (BNP) Level
  • olmesartan medoxomil + candesartan cilexetil placebo
  • olmesartan medoxomil placebo + candesartan cilexetil
  • Bron, France
  • +10 more
Dec 20, 2018

Essential Hypertension Trial in Tokyo (CS-3150, olmesartan medoxomil)

Completed
  • Essential Hypertension
  • Tokyo, Japan
    (unnamed)
Dec 19, 2018

Essential Hypertension Trial in Worldwide (olmesartan medoxomil + amlodipine + hydroclororthiazide + , Olmesartan medoxomil +

Completed
Has Results
  • Essential Hypertension
  • olmesartan medoxomil + amlodipine + hydroclororthiazide + placebo
  • +3 more
  • Antwerp, Belgium
  • +132 more
Dec 20, 2018

Essential Hypertension Trial in Worldwide (olmesartan medoxomil (OM)/hydrochlorothiazide (HCTZ) tablets and , olmesartan

Completed
Has Results
  • Essential Hypertension
  • olmesartan medoxomil (OM)/hydrochlorothiazide (HCTZ) tablets and placebo
  • +2 more
  • Pleven, Bulgaria
  • +54 more
Dec 20, 2018

Essential Hypertension Trial in Germany (olmesartan medoxomil, amlodipine)

Completed
  • Essential Hypertension
  • Hamburg, Germany
  • +5 more
Dec 20, 2018

Essential Hypertension Trial in Worldwide (olmesartan medoxomil (OM)+ hydrochlorothiazide (HCTZ) tablets, olmesartan medoxomil

Completed
Has Results
  • Essential Hypertension
  • olmesartan medoxomil (OM)+ hydrochlorothiazide (HCTZ) tablets
  • olmesartan medoxomil (OM)/ hydrochlorothiazide (HCTZ) 20mg/25mg
  • Brugge, Belgium
  • +40 more
Dec 20, 2018

Essential Hypertension Trial in Germany (olmesartan medoxomil, amlodipine, hydrochlorothiazide)

Completed
  • Essential Hypertension
  • olmesartan medoxomil
  • +2 more
  • Leipzig, Germany
  • +4 more
Dec 20, 2018

Essential Hypertension, Carotid Plaque Trial in Sesto Fiorentino (Atenolol, olmesartan medoxomil)

Terminated
  • Essential Hypertension
  • Carotid Plaque
  • Sesto Fiorentino, Italy
    (unnamed)
Dec 20, 2018